Projects per year
Fingerprint
Dive into the research topics where Johnny Duerinck is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
IOF3021: IOF GEAR: Artificial Intelligence from bench to bedside in neurology, neurosurgery and psychiatry
Engelborghs, S., Nagels, G., Bruneau, M., Vanderbruggen, N., Baeken, C., Crunelle, C., Moens, M., Duerinck, J., Van Schependom, J., Bjerke, M., Van de Steen, F., De Smedt, A., D'Haeseleer, M., De Raedt, S., Bissay, V., Versijpt, J., Flamez, A., Seynaeve, L., Hostenbach, S., Jansen, A. & Laton, J.
1/01/22 → 31/12/26
Project: Applied
-
IMEC11: ICON Project AIM - AIM-Automated Intraoperative Measurements for AR-guided surgery
Duerinck, J. & Scheerlinck, T.
1/09/21 → 31/08/23
Project: Applied
-
EUAR56: Horizon 2020: HosmartAI: Hospital Smart development based on AI.
Vranken, W., Schoors, D., De Canck, H., Vandemeulebroucke, J., Duerinck, J., Olsen, C., Van Dooren, S. & Quinn, P.
1/01/21 → 31/05/24
Project: Fundamental
-
IRP20: TumorScope: Leveraging VUB and UZ Brussels expertise towards a digital health research platform.
Vranken, W., Vandemeulebroucke, J., Cornu, P., Forsyth, R., Quinn, P., Van Dooren, S. & Duerinck, J.
1/11/19 → 31/10/24
Project: Fundamental
-
IMEC8: ICON project SARA: "Augmented Reality assistance for Surgery"
Duerinck, J. & Scheerlinck, T.
1/10/18 → 30/09/21
Project: Applied
Research output
-
An international validation of the AO spine subaxial injury classification system
AO Spine Subaxial Classification Group Members, Karamian, B. A., Schroeder, G. D., Lambrechts, M. J., Canseco, J. A., Oner, C., Vialle, E., Rajasekaran, S., Dvorak, M. R., Benneker, L. M., Kandziora, F., Schnake, K., Kepler, C. K. & Vaccaro, A. R., Jan 2023, In: European Spine Journal. 32, 1, p. 46-54 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB)
Schwarze, J. K., Geens, W., Tijtgat, J., Awada, G., Vanbinst, A., Everaert, H., Seynaeve, L., Michotte, A., Bruneau, M., VAN RIET, I., Tuyaerts, S., Duerinck, J. & Neyns, B., 3 Jun 2022.Research output: Unpublished contribution to conference › Poster
-
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB)
Schwarze, J. K., Geens, W., Tijtgat, J., Awada, G., Seynaeve, L., Vanbinst, A-M., Everaert, H., Michotte, A., Bruneau, M., Van Riet, I., Tuyaerts, S., Duerinck, J. & Neyns, B., 1 Jun 2022, In: Journal of Clinical Oncology. 40, 16, 2033.Research output: Contribution to journal › Meeting abstract (Journal)
Open Access -
A PHASE I CLINICAL TRIAL ON THE INTRACRANIAL ADMINISTRATION OF INCREASING DOSES OF IPILIMUMAB PLUS FIXED DOSE NIVOLUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGB)
Geens, W., Schwarze, J. K., Tijtgat, J., Lescrauwaet, L., Tuyaerts, S., Geeraerts, X., Stevens, L., Vanbinst, A-M., Everaert, H., Bruneau, M., Duerinck, J. & Neyns, B., Nov 2022, In: Neuro-oncology. 24, p. 62-62 1 p.Research output: Contribution to journal › Meeting abstract (Journal)
-
A phase I clinical trial on the intracranial administration of increasing doses of ipilimumab plus fixed dose nivolumab in patients with recurrent glioblastoma (rGB).
Geens, W., Schwarze, J. K., Tijtgat, J., Lescrauwaet, L. C., Tuyaerts, S., Geeraerts, X., Stevens, L., Vanbinst, A., Everaert, H., Bruneau, M., Duerinck, J. & Neyns, B., 2022.Research output: Unpublished contribution to conference › Poster
Prizes
-
2019 SNO/EANO Reciprocal Grant Abstract Award
Duerinck, Johnny (Recipient), 24 Nov 2019
Prize: National/international honour
Activities
-
Belgian Association for Neuro-Oncology Meeting
Michaël Bruneau (Participant) & Johnny Duerinck (Organiser)
9 Dec 2022Activity: Participating in or organising an event › Participation in conference
-
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).
Wietse Geens (Speaker), Julia Katharina Schwarze (Contributor), Cleo Bertels (Contributor), Jens Tijtgat (Contributor), Gil Awada (Contributor), F Vaeyens (Contributor), Louise Cras (Contributor), Anne Vanbinst (Contributor), Hendrik Everaert (Contributor), Alex Michotte (Contributor), Toon Janssen (Contributor), Ben Caljon (Contributor), Thomas Cauwenbergh (Contributor), Michaël Bruneau (Contributor), Ramses Forsyth (Contributor), Sandra Tuyaerts (Contributor), Bart Neyns (Contributor) & Johnny Duerinck (Contributor)
26 Mar 2022Activity: Talk or presentation › Talk or presentation at a conference
-
Prognostic value of 0-(2-[18F]-fluoroethyl)-L-tyrosine PET in patients with recurrent glioblastoma.
Wietse Geens (Speaker), Stephanie Du Four (Contributor), S VAN LAERE (Contributor), Julia Katharina Schwarze (Contributor), Gil Awada (Contributor), Michaël Bruneau (Contributor), Jens Tijtgat (Contributor), Hendrik Everaert (Contributor), Bart Neyns (Contributor) & Johnny Duerinck (Contributor)
26 Mar 2022Activity: Talk or presentation › Talk or presentation at a conference
-
Breast Cancer Debate of the Year
Johnny Duerinck (Speaker)
29 Jan 2021Activity: Talk or presentation › Talk or presentation at a conference
-
Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): a multi-cohort adaptive phase I clinical trial
Julia Katharina Schwarze (Speaker), Wietse Geens (Contributor), Jens Tijtgat (Contributor), Gil Awada (Contributor), Anne-Marie Van Binst (Contributor), Hendrik Everaert (Contributor), Laura Seynaeve (Contributor), Alex Michotte (Contributor), Michaël Bruneau (Contributor), I VAN RIET (Contributor), Sandra Tuyaerts (Contributor), Johnny Duerinck (Contributor) & Bart Neyns (Contributor)
16 Sep 2021 → 21 Sep 2021Activity: Talk or presentation › Talk or presentation at a conference
Press/Media
-
Immuuntherapie beloftevol voor patiënten met glioblastoom
4/12/18
1 item of Media coverage
Press/Media: Other
-
Belgen: mogelijk doorbraak bij glioblastoom (langer leven)
7/11/18
1 Media contribution
Press/Media: Other
-
Glioblastoom:immuuntherapie lokaal toedienen in de hersenen (UZ Brussel)
5/11/18
1 Media contribution
Press/Media: Other
-
UZ Brussel geeft patiënten met recidiverend glioblastoom nieuwe hoop
5/11/18
1 Media contribution
Press/Media: Other
-
Thesis
-
Targeting VEGF(R) in the treatment of recurrent glioblastoma
Author: Duerinck, J., Neyns, B., De Ridder, M., Smolders, I., Van Velthoven, V., De Vleeschouwer, S. & Reardon, D., 6 Sep 2017Supervisor: Neyns, B. (Promotor), De Ridder, M. (Jury), Smolders, I. (Jury), Van Velthoven, V. (Jury), De Vleeschouwer, S. (External person) (Jury) & Reardon, D. (External person) (Jury)
Student thesis: Doctoral Thesis